Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
Overview of attention for article published in Lancet Oncology, December 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (99th percentile)
Mentioned by
- news
- 29 news outlets
- blogs
- 4 blogs
- policy
- 3 policy sources
- 36 X users
- patent
- 22 patents
- f1000
- 1 research highlight platform
- guideline
- 10 clinical guideline sources
Readers on
- mendeley
- 1358 Mendeley